213 related articles for article (PubMed ID: 26946771)
1. Acute Myocardial Infarction during Induction Chemotherapy for Acute MLL t(4;11) Leukemia with Lineage Switch and Extreme Leukocytosis.
Colović N; Bogdanović A; Virijević M; Vidović A; Tomin D
Srp Arh Celok Lek; 2015; 143(11-12):734-8. PubMed ID: 26946771
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
3. A case of therapy-related ALL with MLL gene rearrangement following treatment of breast cancer.
Cho J; Hur M; Moon HW; Yun YM; Lee CH; Lee HG
Korean J Lab Med; 2010 Jun; 30(3):255-9. PubMed ID: 20603585
[TBL] [Abstract][Full Text] [Related]
4. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Daver N; Thomas D; Ravandi F; Cortes J; Garris R; Jabbour E; Garcia-Manero G; Borthakur G; Kadia T; Rytting M; Konopleva M; Kantarjian H; O'Brien S
Haematologica; 2015 May; 100(5):653-61. PubMed ID: 25682595
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
[TBL] [Abstract][Full Text] [Related]
6. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
7. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian HM; O'Brien S; Smith TL; Cortes J; Giles FJ; Beran M; Pierce S; Huh Y; Andreeff M; Koller C; Ha CS; Keating MJ; Murphy S; Freireich EJ
J Clin Oncol; 2000 Feb; 18(3):547-61. PubMed ID: 10653870
[TBL] [Abstract][Full Text] [Related]
8. [Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007].
Arteaga-Ortiz L; Buitrón-Santiago N; Rosas-López A; Rosas-Arzate G; Armengolt-Jiménez A; Aguayo A; López-Karpovitch X; Crespo-Solís E
Rev Invest Clin; 2008; 60(6):459-69. PubMed ID: 19378832
[TBL] [Abstract][Full Text] [Related]
9. Leukocytosis: a new look at an old marker for acute myocardial infarction.
Green SM; Vowels J; Waterman B; Rothrock SG; Kuniyoshi G
Acad Emerg Med; 1996 Nov; 3(11):1034-41. PubMed ID: 8922012
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic bone marrow transplantation in a case of acute lymphoblastic leukemia with positive Philadelphia chromosome].
Kitoh T; Tabata Y; Akiyama Y; Kiriyama Y; Kubota M; Mikawa H
Rinsho Ketsueki; 1989 May; 30(5):680-5. PubMed ID: 2795882
[TBL] [Abstract][Full Text] [Related]
11. Effects of chemotherapy agents used to treat pediatric acute lymphoblastic leukemia patients on bone parameters and longitudinal growth of juvenile mice.
Straszkowski L; Jovic T; Castillo-Tandazo W; Ritchie DS; Purton LE
Exp Hematol; 2020 Feb; 82():1-7. PubMed ID: 32006607
[TBL] [Abstract][Full Text] [Related]
12. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
[TBL] [Abstract][Full Text] [Related]
13. [Fatal bone marrow necrosis and fat embolism following sepsis in a patient with acute lymphoblastic leukemia after consolidation chemotherapy].
Takeda W; Sumi M; Kirihara T; Kurihara T; Sato K; Fujikawa Y; Shimizu I; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2014 Feb; 55(2):254-7. PubMed ID: 24598195
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis during myelosuppression in a patient with central nervous system leukemia: A case report.
Le Y; Li H; Wan C; Long Y; Liu Z
Medicine (Baltimore); 2018 Nov; 97(45):e13091. PubMed ID: 30407314
[TBL] [Abstract][Full Text] [Related]
15. Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.
Rayes A; McMasters RL; O'Brien MM
Pediatr Blood Cancer; 2016 Jun; 63(6):1113-5. PubMed ID: 26914337
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar toxicity following hyperCVAD regimen for acute lymphoblastic leukaemia.
Koh LP; Lim LC
Br J Haematol; 1999 Mar; 104(3):644-5. PubMed ID: 10086812
[No Abstract] [Full Text] [Related]
17. Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy.
Wu JR; Shih PC; Li C; Chao HL; Wang HC; Chiang YM; Liu YJ; Hsu SC; Yao CY; Chen LH; Lin CC; Tien HF; Chou WC
J Hematop; 2023 Jun; 16(2):103-109. PubMed ID: 38175441
[TBL] [Abstract][Full Text] [Related]
18. [Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia].
Yoshimi A; Taoka K; Nakasone H; Iijima K; Kida M; Iki S; Urabe A; Usuki K
Rinsho Ketsueki; 2006 Dec; 47(12):1533-8. PubMed ID: 17233472
[TBL] [Abstract][Full Text] [Related]
19. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
Tomita N; Fujita H; Koharazawa H; Maruta A; Kodama F; Yamamoto T; Kobayashi S; Okubo T
Rinsho Ketsueki; 1997 Feb; 38(2):135-41. PubMed ID: 9059068
[TBL] [Abstract][Full Text] [Related]
20. Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.
Toft N; Birgens H; Abrahamsson J; Bernell P; Griškevičius L; Hallböök H; Heyman M; Holm MS; Hulegårdh E; Klausen TW; Marquart HV; Jónsson OG; Nielsen OJ; Quist-Paulsen P; Taskinen M; Vaitkeviciene G; Vettenranta K; Åsberg A; Schmiegelow K
Eur J Haematol; 2013 May; 90(5):404-12. PubMed ID: 23461707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
